跳至主要内容
临床试验/NCT00126802
NCT00126802Unknown1 期

The Role of Tomotherapy (Dynamic IMRT and Megavoltage CT Scanning) in Hypofractionated/Dose Escalated Conformal Radiation Treatment Using Magnetic Resonance Spectroscopy (MRS) Scans to Predict and Document the Pattern of Local Failure for High Risk Prostate Cancer

AHS Cancer Control Alberta2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2005年4月最近更新:
适应症

试验速览

阶段
1 期
入组人数
60
试验地点
2
主要终点
Rectal Toxicity

研究概览

简要总结

Helical tomotherapy is being used to treat the prostate gland, local rates of spread and regional lymph nodes whilst sparing gross structures. The radiation to the gross disease in the prostate is hypofractionated and dose escalated. Magnetic resonance spectroscopic imaging (MRSI) is incorporated into pre- and post-treatment evaluation.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
— 至 75 Years(Child, Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • High risk localized prostate cancer

排除标准

  • Low/intermediate risk, metastatic cancer
  • Patient refusal

结局指标

主要结局

Rectal Toxicity

时间窗: 5 weeks

Determine the acute and late rectal toxicity of high-dose short-course hypofractionated radiotherapy in five weeks in the treatment of high rish prostate cancer.

次要结局

  • prostate-specific antigen (PSA) and MRSI disease control(3 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验